{"8.64":{"start":"8.639","dur":"8.23","text":"&gt;&gt;Chrystia Freeland: Marc is holding now a\ngreat invention of his. And 1984 turns out"},"16.87":{"start":"16.869","dur":"5.16","text":"to be an important year for this entire panel.\nThat&#39;s the year that Guy got his important"},"22.03":{"start":"22.029","dur":"4.08","text":"not grant, but contract from the government\nof Canada. It&#39;s the year that Marc -- and"},"26.11":{"start":"26.109","dur":"5.65","text":"correct me if I&#39;m mistaken here -- read about\nhow syringes were being reused and that was"},"31.76":{"start":"31.759","dur":"6.951","text":"spreading HIV. One of those heart-wrenching\nstories that we often read. But unlike most"},"38.71":{"start":"38.71","dur":"4.22","text":"of us, when Marc read this, he decided to\nchange his life and do something about it."},"42.93":{"start":"42.93","dur":"4.91","text":"And that&#39;s what he&#39;s been doing ever since,\nboth founding a company producing syringes"},"47.84":{"start":"47.84","dur":"6.85","text":"which can&#39;t be reused, and also an NGO that\nspreads awareness of it."},"54.69":{"start":"54.69","dur":"4.509","text":"Sitting next to him is Sipho Moyo. I&#39;m so\nglad that Sipho is here, because so often"},"59.20":{"start":"59.199","dur":"5.78","text":"I think a lot of our discussion is going to\nbe about Africa, and so often I moderate panels,"},"64.98":{"start":"64.979","dur":"5.571","text":"especially at conferences like this, where\nWestern people talk a lot about the problems"},"70.55":{"start":"70.55","dur":"5.7","text":"of Africa in very wise ways and nod our heads.\nSo it&#39;s good to have at least one actual African"},"76.25":{"start":"76.25","dur":"5.75","text":"here. Sipho has 18 years of development experience\nin Africa. She has worked all over the continent,"},"82.00":{"start":"82","dur":"3.591","text":"Tanzania, most recently Nigeria. She&#39;s in\nJohannesburg now."},"85.59":{"start":"85.591","dur":"6.769","text":"She emphasized to me that she is not Dambisa\nMoyo, although she has some controversial"},"92.36":{"start":"92.36","dur":"6.579","text":"and sharp views herself and her father did\nteach Dambisa and their friends."},"98.94":{"start":"98.939","dur":"1.331","text":"&gt;&gt;Sipho Moyo: Dambisa&#39;s father taught me.\n&gt;&gt;Chrystia Freeland: Dambisa&#39;s father taught"},"100.27":{"start":"100.27","dur":"6.139","text":"her. So we have connections here.\nAnd then, of course, famous to everyone who"},"106.41":{"start":"106.409","dur":"2.14","text":"lives in Britain, Dame Barbara Stocking. I\nfeel I should curtsey when --"},"108.55":{"start":"108.549","dur":"5.11","text":"&gt;&gt;Barbara Stocking: Could you stop saying\n&quot;dame&quot;? It doesn&#39;t sort of going with Oxfam"},"113.66":{"start":"113.659","dur":"4.181","text":"somehow. Or just drop that one.\n&gt;&gt;Chrystia Freeland: Who is the CEO of Oxfam,"},"117.84":{"start":"117.84","dur":"6.529","text":"Great Britain. This is one of the world&#39;s\nmost admired and accomplished philanthropies."},"124.37":{"start":"124.369","dur":"5.39","text":"Four and a half thousand employees, a budget\nof three and a half million pounds, doing"},"129.76":{"start":"129.759","dur":"5.021","text":"huge and really important work around the\nworld. And it&#39;s really important, making some"},"134.78":{"start":"134.78","dur":"5.23","text":"really important connections that we&#39;ll talk\nabout, I hope, on this panel, about connecting"},"140.01":{"start":"140.01","dur":"5.18","text":"the dots between what businesses do in their\nbusiness and how they can make the world a"},"145.19":{"start":"145.19","dur":"2.81","text":"better place, a little bit what we&#39;ve been\ntalking about with Guy."},"148.00":{"start":"148","dur":"3.959","text":"How we&#39;re going to organize this panel is\nI&#39;m going to ask our brilliant panelists questions"},"151.96":{"start":"151.959","dur":"6.36","text":"for about 15 minutes. I hope they&#39;ll all jump\nin and very kindly but forcefully disagree"},"158.32":{"start":"158.319","dur":"7.861","text":"with one another where they have reason to.\nThen we will have about 15 or 20 minutes for"},"166.18":{"start":"166.18","dur":"6.35","text":"questions, and we will end promptly at 5:00,\nI promise you dear Zeitgeisters."},"172.53":{"start":"172.53","dur":"8.629","text":"So starting with Marc, talk to us a little\nbit, Marc, about -- I mean, the idea seems"},"181.16":{"start":"181.159","dur":"9.041","text":"so obvious that syringes which are reused\ncan spread disease. And yet, you have found"},"190.20":{"start":"190.2","dur":"7.61","text":"it far from obvious and far from easy to actually\nhave these non-reusable syringes be the ones"},"197.81":{"start":"197.81","dur":"3.599","text":"that are being used.\nSo why is it so hard? What are the obstacles?"},"201.41":{"start":"201.409","dur":"5.72","text":"&gt;&gt;Marc Koska: I wish I knew. When I started\nin 1984, I thought I&#39;ll come up with a design,"},"207.13":{"start":"207.129","dur":"3.211","text":"two years later, I&#39;ll go traveling.\nBut it actually has --"},"210.34":{"start":"210.34","dur":"2.92","text":"&gt;&gt;Chrystia Freeland: Tell us -- describe the\ndesign briefly."},"213.26":{"start":"213.26","dur":"6.35","text":"&gt;&gt;Marc Koska: It&#39;s still a big problem. Basically,\nfor the audience, the -- a normal syringe"},"219.61":{"start":"219.61","dur":"5.61","text":"can be reused because it&#39;s just a plastic\nbarrel with a plunger in it. What I designed"},"225.22":{"start":"225.22","dur":"5.73","text":"after three years of research is this product.\nIt looks like a normal syringe. And after"},"230.95":{"start":"230.95","dur":"6.42","text":"use, in the patient, it&#39;s discarded. If someone\nthen tries to pick it up and refill it, the"},"237.37":{"start":"237.37","dur":"4.75","text":"action of pulling back the plunger makes it\nlock and break, and it can&#39;t be used again."},"242.12":{"start":"242.12","dur":"7.03","text":"And the key to this was that it&#39;s made on\nexisting equipment in the manufacturing systems"},"249.15":{"start":"249.15","dur":"2.65","text":"that exist. There are about 600 factories\nin the world."},"251.80":{"start":"251.8","dur":"4.71","text":"So what I wanted to do was come up with a\ndesign which didn&#39;t force any change or extra"},"256.51":{"start":"256.51","dur":"7.39","text":"cost to manufacturers, can be used in the\nsame way, and costs exactly the same as a"},"263.90":{"start":"263.9","dur":"1.519","text":"normal syringe.\nThank you."},"265.42":{"start":"265.419","dur":"5.851","text":"&gt;&gt;Chrystia Freeland: Now, if you doubt the\nimportance of that syringes, I urge you during"},"271.27":{"start":"271.27","dur":"6.35","text":"the breaks to accost Marc and ask him to play\nyou a video on his phone -- I&#39;m afraid it&#39;s"},"277.62":{"start":"277.62","dur":"7.24","text":"not an Android; it&#39;s actually an iPhone -- of\nsome scenes that you&#39;ve taken -- some covert"},"284.86":{"start":"284.86","dur":"5.179","text":"scenes you&#39;ve taken inside clinics.\n&gt;&gt;Marc Koska: It&#39;s still going on, today,"},"290.04":{"start":"290.039","dur":"5.411","text":"something like 60% of all injections in India\nare unsafe. The same system -- or the same"},"295.45":{"start":"295.45","dur":"5.38","text":"numbers are apparent in most developing world\ncountries. And it&#39;s not really clear, there&#39;s"},"300.83":{"start":"300.83","dur":"2.48","text":"not one particular reason.\n&gt;&gt;Chrystia Freeland: People going in to get"},"303.31":{"start":"303.31","dur":"4.06","text":"immunizations for their babies?\n&gt;&gt;Marc Koska: Immunizations are not too bad"},"307.37":{"start":"307.37","dur":"5.99","text":"if they&#39;re U.N. run or NGO run, because there&#39;s\na mandate for immunizations to be given with"},"313.36":{"start":"313.36","dur":"6.03","text":"these safe syringes. Those represent only\na small percentage. The vast majority of injections"},"319.39":{"start":"319.39","dur":"8.029","text":"are not in any way safe if they don&#39;t use\nthis or they don&#39;t use correct procedure."},"327.42":{"start":"327.419","dur":"4.521","text":"So we end up with something like 1.3 million\ndeaths -- World Health Organization number"},"331.94":{"start":"331.94","dur":"6.36","text":"-- being caused every single year, which is\ntwice the amount of the death toll of malaria"},"338.30":{"start":"338.3","dur":"5.94","text":"even. And what angers me is, this is caused\nby a doctor or a nurse. This isn&#39;t, you know,"},"344.24":{"start":"344.24","dur":"6.66","text":"an innocent mosquito. This is actually being\ntransmitted to the patients via a health care"},"350.90":{"start":"350.9","dur":"3.81","text":"worker.\n&gt;&gt;Chrystia Freeland: Do you find government"},"354.71":{"start":"354.71","dur":"3.629","text":"bureaucracies an obstacle?\n&gt;&gt;Marc Koska: Yes."},"358.34":{"start":"358.339","dur":"5.551","text":"&gt;&gt;Chrystia Freeland: How and why?\n&gt;&gt;Marc Koska: There&#39;s a lot of corruption."},"363.89":{"start":"363.89","dur":"3.279","text":"There&#39;s a lot of bribery. You know, there\nare more -- at the moment, there are more"},"367.17":{"start":"367.169","dur":"4.93","text":"normal syringe manufacturers in the world\nthan there are safety syringe manufacturers"},"372.10":{"start":"372.099","dur":"5.86","text":"in the world. And they seem to win. I don&#39;t\nknow how it works out, but they seem to keep"},"377.96":{"start":"377.959","dur":"6.01","text":"the status quo going where they&#39;re supplying,\nyou know, sometimes unsterile products, but"},"383.97":{"start":"383.969","dur":"6.361","text":"they&#39;re in a package. They look sterile. And\nthey&#39;re coming in at very, very underpriced"},"390.33":{"start":"390.33","dur":"3.3","text":"levels, so they&#39;re just flooding the market\nwith these products."},"393.63":{"start":"393.63","dur":"4.49","text":"It is particularly dangerous, because syringes\nare the most commonly used piece of medical"},"398.12":{"start":"398.12","dur":"5.469","text":"equipment in the world. So if you&#39;ve got a\nbase where disease is being spread from the"},"403.59":{"start":"403.589","dur":"5","text":"actual most commonly used medical product\nin the world, that&#39;s pretty perverse."},"408.59":{"start":"408.589","dur":"7.372","text":"&gt;&gt;Chrystia Freeland: Now, Marc, if I were\nan African health minister and you came to"},"415.96":{"start":"415.961","dur":"5.029","text":"sing the virtues of your syringe, I might\nsay to you, but, come on, you&#39;re selling me"},"420.99":{"start":"420.99","dur":"3.68","text":"this stuff. Aren&#39;t you just trying to make\nlots of money?"},"424.67":{"start":"424.67","dur":"3.41","text":"So what&#39;s your come-back?\n&gt;&gt;Marc Koska: Well, that is obviously true."},"428.08":{"start":"428.08","dur":"5.74","text":"I do run a company, and we license these to\n13 manufacturers now around the world and"},"433.82":{"start":"433.82","dur":"2.01","text":"make a couple of million of these units a\nday."},"435.83":{"start":"435.83","dur":"8.47","text":"But it is absolutely true. And I think whether\nI directly profit or not, I&#39;m not really -- don&#39;t"},"444.30":{"start":"444.3","dur":"4.17","text":"really have time to defend. What I want to\ndo is change the scene quite dramatically."},"448.47":{"start":"448.47","dur":"7","text":"I want to see if I can put into action an\nidea that I&#39;ve got where we open-source good"},"455.47":{"start":"455.47","dur":"5.48","text":"ideas, where good ideas are no longer constrained\nunder commercial reality."},"460.95":{"start":"460.95","dur":"4.35","text":"And to the audience, you&#39;ll think I&#39;m mad,\nbecause, obviously, you live in the commercial"},"465.30":{"start":"465.3","dur":"3.859","text":"world where it&#39;s dog eat dog and every margin\ncounts. But, actually --"},"469.16":{"start":"469.159","dur":"3.57","text":"&gt;&gt;Chrystia Freeland: They&#39;re muzzled. It&#39;s\na conference. They&#39;re not fighting."},"472.73":{"start":"472.729","dur":"4.68","text":"&gt;&gt;Marc Koska: What I might profit out of this\nproduct does not matter. What matters is that"},"477.41":{"start":"477.409","dur":"6.131","text":"this reaches its humanitarian scale and it\ndoes its job and we eradicate that 1.3 million."},"483.54":{"start":"483.54","dur":"4.859","text":"&gt;&gt;Chrystia Freeland: Marc, I think you&#39;re\ntrying to think about ways to get around this"},"488.40":{"start":"488.399","dur":"4.75","text":"potential conflict, where you&#39;re selling a\nsolution, but you also run a company that"},"493.15":{"start":"493.149","dur":"2.52","text":"wants to make money. How can you square that\ncircle?"},"495.67":{"start":"495.669","dur":"5.101","text":"&gt;&gt;Marc Koska: Well, the idea that I&#39;m working\non at the moment is that we kind of eradicate"},"500.77":{"start":"500.77","dur":"2.91","text":"the company angle and we try and transfer\n--"},"503.68":{"start":"503.68","dur":"4.27","text":"&gt;&gt;Chrystia Freeland: Shut down your company?\n&gt;&gt;Marc Koska: Shut down the company selectively,"},"507.95":{"start":"507.95","dur":"4.11","text":"and I use that word very advisedly. Because\nthis isn&#39;t a launch of the idea. This is just"},"512.06":{"start":"512.06","dur":"6.32","text":"a conceptual description of the idea. The\nidea would be that we somehow shut down the"},"518.38":{"start":"518.38","dur":"6.69","text":"company and we pass over the designs to an\nopen sourcing system where we --"},"525.07":{"start":"525.07","dur":"2.98","text":"&gt;&gt;Chrystia Freeland: Going to go Google?\n&gt;&gt;Marc Koska: We go Google, we allow everyone"},"528.05":{"start":"528.05","dur":"5.8","text":"to manufacture the product. And as long as\nthey meet constraints of quality and targets"},"533.85":{"start":"533.85","dur":"7.1","text":"of production, that, you know, somehow we\nreward them with an open source type royalty"},"540.95":{"start":"540.95","dur":"2.92","text":"rebate or something along those lines.\n&gt;&gt;Chrystia Freeland: How will that make you"},"543.87":{"start":"543.87","dur":"2.7","text":"more effective, you do think?\n&gt;&gt;Marc Koska: Well, I think it takes away,"},"546.57":{"start":"546.57","dur":"4.56","text":"one, the elephant in the room, the one that\nyou mentioned, of, &quot;Is he making money out"},"551.13":{"start":"551.13","dur":"5.61","text":"of it?&quot; But also it allows me to be much more\nvocal and hold a gun to these ministers&#39; heads."},"556.74":{"start":"556.74","dur":"1.46","text":"&gt;&gt;Chrystia Freeland: Hold guns to the ministers&#39;\nheads?"},"558.20":{"start":"558.2","dur":"3.39","text":"&gt;&gt;Marc Koska: I&#39;m going to say, &quot;Change, or\nyou&#39;re part of the problem.&quot;"},"561.59":{"start":"561.59","dur":"7.03","text":"&gt;&gt;Chrystia Freeland: How -- you have to live.\nSo how can you take the financial element"},"568.62":{"start":"568.62","dur":"4.46","text":"out of the equation? Do you need a sugar daddy\nto come in?"},"573.08":{"start":"573.08","dur":"3.1","text":"&gt;&gt;Marc Koska: Yeah, yeah. We&#39;re looking at\nexactly that. And sugar daddies, let&#39;s face"},"576.18":{"start":"576.18","dur":"6.72","text":"it, normally set up funds. And their ultimate\nreward is to save a life or to improve a life."},"582.90":{"start":"582.9","dur":"4.48","text":"And if -- you know, if the dialogue goes along,\nlook, if you gave me &quot;X&quot; million dollars and"},"587.38":{"start":"587.38","dur":"5.16","text":"I could save &quot;X&quot; million lives, would you\nbe willing to do it? I think there are plenty"},"592.54":{"start":"592.54","dur":"3.89","text":"out there that want that.\nI think it only works with certain products."},"596.43":{"start":"596.43","dur":"5.49","text":"They&#39;ve got to be pretty well developed. They&#39;ve\ngot to have proven that they deserve a place"},"601.92":{"start":"601.92","dur":"7.08","text":"in the world and that they can be scaled and\nbe just as effective scaled without any detriment."},"609.00":{"start":"609","dur":"5.12","text":"And I feel this is a no-brainer, because we&#39;ve\ngot a market already out there. We&#39;ve got"},"614.12":{"start":"614.12","dur":"5.06","text":"a manufacturing system out there already,\nand they are just making almost this product"},"619.18":{"start":"619.18","dur":"1.79","text":"but not quite. And the changeover is pretty\neasy."}}